@article{oai:repo.qst.go.jp:00084342,
 author = {Murakami, Naoya and Ando, Ken and Murata, Masumi and Murata, Kazutoshi and Ohno, Tatsuya and Aoshika, Tomomi and Kato, Shingo and Okonogi, Noriyuki and I Saito, Anneyuko and Joo-Young, Kim and Kumai, Yasuko and Yoshioka, Yasuo and Sekii, Shuhei and Tsujino, Kayoko and Lowanichkiattikul, Chairat and Pattaranutaporn, Poompis and Kaneyasu, Yuko and Nakagawa, Tomio and Watanabe, Miho and Uno, Takashi and Umezawa, Rei and Jingu, Keiichi and Kanemoto, Ayae and Wakatsuki, Masaru and Shirai, Katsuyuki and Igaki, Hiroshi and Itami, Jun and Ken, Ando and Kazutoshi, Murata and Tatsuya, Ohno and Shingo, Kato and Noriyuki, Okonogi and Takashi, Uno and Keiichi, Jingu and Masaru, Wakatsuki and Katsuyuki, Shirai and Jun, Itami},
 issue = {1},
 journal = {Gynecologic oncology},
 month = {Jul},
 note = {The majority of uterine cervical cancer is known to be related to human papillomavirus (HPV), and HPV-related tumors are known to be radio-sensitive. In the management of HPV-related oropharyngeal cancer, de-intensification of treatment has been attempted; however, no such attempt is performed in the management of cervical cancer. The aim of this study was to identify a group of patients who can safely be treated by de-escalated treatment intensity.},
 pages = {105--109},
 title = {Why not de-intensification for uterine cervical cancer?},
 volume = {163},
 year = {2021}
}